Anna R Kwilas - FDA Investigator Report

Overview Statistics

4
Total Inspections
3
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 6 days
Shortest Inspection: 5 days
Average Length: 5.3 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Anna R Kwilas's Recent Inspections

DateCompanyCityCountryFEI Number483
2024-04-05Adaptimmune LLCPhiladelphiaUnited States3013525969
2024-02-16Resilience US, IncDurhamUnited States3015451326
2022-11-16Krystal Biotech, Inc.PittsburghUnited States3013498720
2022-02-18Lonza Houston, IncHoustonUnited States3013629214

Sign Up to get the complete report.

Download 483s and EIRs for Anna R Kwilas

Anna R Kwilas - Co-Inspectors

NameInspectionsLast Inspection
Wei Wang22022
Elvira R Argus12024
Laura K Demaster12024
Viviana R Ramirez12024
Sharmila Shrestha12024
Jie He12024
Jianyang Wang12022
Jakob Reiser12022
Carl A Perez12022
Bo Liang12022
Priscilla M Pastrana12022
Christian Lynch12022

Anna R Kwilas's Active Locations

  • United States

Anna R Kwilas's Year-wise Inspection Count

  • 2022:2 inspections
  • 2024:2 inspections
Last Updated: 2025-05-14 06:11:22